NCT03224351 A Study Evaluating the Safety and Efficacy of VX-659 Combination Therapy in Subjects With Cystic Fibrosis Status COMPLETED Phase PHASE2
NCT03219164 Study of Aztreonam for Inhalation in Children With Cystic Fibrosis and New Infection of the Airways by Pseudomonas Aeruginosa Bacteria Status TERMINATED Phase PHASE3
NCT03205904 Nutritional Intervention and Glycemic Improvement in Patients With Pre-diabetic Cystic Fibrosis. Status COMPLETED Phase NA
NCT03181932 AeroVanc in the Treatment of Methicillin-resistant Staphylococcus Aureus Infection in Patients With Cystic Fibrosis Status COMPLETED Phase PHASE3
NCT03173573 A Study to Assess the Safety, Tolerability and PK Profile of FDL176 in Healthy and CF Participants Status COMPLETED Phase PHASE1
NCT03150719 A Study to Evaluate Safety, Efficacy, and Tolerability of TEZ/IVA in Orkambi® (Lumacaftor/Ivacaftor) -Experienced Subjects With Cystic Fibrosis (CF) Status COMPLETED Phase PHASE3
NCT03145051 Efficacy of Nasal Irrigation With Respimer® Netiflow® vs Saline Among Patients With Cystic Fibrosis and Chronic Rhinosinusitis Status UNKNOWN Phase NA
NCT03140527 Study Assessing the Safety, Tolerability, Pharmacokinetics, Food Effect, and Drug-Drug Interactions of PTI-801 in Healthy Volunteers, and Safety, Tolerability, and Pharmacokinetics of PTI-801 in Subjects With Cystic Fibrosis Status COMPLETED Phase PHASE1
NCT03125395 A Rollover Safety Study of Lumacaftor/Ivacaftor in Subjects Aged 2 Years and Older With Cystic Fibrosis, Homozygous for the F508del-CFTR Mutation Status COMPLETED Phase PHASE3
NCT03119649 A Study to Evaluate Multiple Doses of GLPG2222 in Adult Subjects With Cystic Fibrosis Status COMPLETED Phase PHASE2
NCT03100214 Effects of an Early Rehabilitation Program During Hospitalization in Patients With Cystic Fibrosis Status COMPLETED Phase NA
NCT03093714 A Study to Evaluate Safety, PK and PD of FDL169 in Cystic Fibrosis Subjects Status COMPLETED Phase PHASE1